Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 32Ovarian Neoplasms 6Neoplasm Metastasis 6Endometrial Neoplasms 5Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Neoplasms 3Advanced Breast Cancer 3Small Cell Lung Carcinoma 2Neoplasms by Site 2Melanoma 2Hereditary Sensory and Autonomic Neuropathies 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Diseases 2Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Recurrence 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Genetic Diseases, Inborn 1Fallopian Tube Neoplasms 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Esophageal Squamous Cell Carcinoma 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

pembrolizumab 3tislelizumab 2Injections 2toripalimab 1atezolizumab 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fulvestrant 1Drug Therapy 1Antineoplastic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Fulvestrant × 30 days × Clear all
NCT07226349 2026-05-27

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
105 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡